McDonald Capital Investors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

McDonald Capital Investors’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-13,500	Closed	-$509K	–	25
2021 Q1	$509K	Buy	+13,500	New	+$337K	0.04%	22

McDonald Capital Investors's FPRX Position: Q2 2021 in Review

McDonald Capital Investors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 13,500 shares — an estimated $509K sold.

McDonald Capital Investors first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $509K in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

McDonald Capital Investors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
McDonald Capital Investors sold 13,500 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $509K.
McDonald Capital Investors first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
McDonald Capital Investors's Five Prime Therapeutics, Inc. position peaked at $509K in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on McDonald Capital Investors's 13F filing for Q2 2021, filed 3 Aug 2021.